Saturn V Capital Management as of Sept. 30, 2025
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 17 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 14.9 | $68M | 801k | 84.90 | |
| Amylyx Pharmaceuticals (AMLX) | 13.7 | $63M | 4.6M | 13.59 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 8.7 | $40M | 301k | 131.80 | |
| Dyne Therapeutics (DYN) | 7.4 | $34M | 2.7M | 12.65 | |
| Cogent Biosciences (COGT) | 6.4 | $29M | 2.0M | 14.36 | |
| Vaxcyte (PCVX) | 6.2 | $28M | 788k | 36.02 | |
| Celcuity (CELC) | 5.1 | $23M | 474k | 49.40 | |
| Cg Oncology (CGON) | 5.1 | $23M | 580k | 40.28 | |
| Disc Medicine (IRON) | 4.9 | $23M | 341k | 66.08 | |
| Pharvaris N V (PHVS) | 4.8 | $22M | 886k | 24.95 | |
| Xenon Pharmaceuticals (XENE) | 4.4 | $20M | 504k | 40.15 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.9 | $18M | 735k | 24.25 | |
| Merus N V (MRUS) | 3.8 | $17M | 184k | 94.15 | |
| Lenz Therapeutics (LENZ) | 3.8 | $17M | 368k | 46.58 | |
| Ocular Therapeutix (OCUL) | 3.0 | $14M | 1.2M | 11.69 | |
| Monopar Therapeutics Com New (MNPR) | 2.8 | $13M | 155k | 81.67 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.0 | $4.4M | 153k | 28.44 |
